Sabal Trust CO raised its stake in shares of Clorox Co. (NYSE:CLX) by 2.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 163,636 shares of the company’s stock after buying an additional 4,571 shares during the period. Clorox comprises about 2.6% of Sabal Trust CO’s holdings, making the stock its 23rd largest position. Sabal Trust CO owned 0.13% of Clorox worth $22,645,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Ngam Advisors L.P. increased its position in shares of Clorox by 5.9% in the first quarter. Ngam Advisors L.P. now owns 48,502 shares of the company’s stock valued at $6,114,000 after buying an additional 2,697 shares during the last quarter. Prudential Financial Inc. increased its stake in Clorox by 209.8% in the first quarter. Prudential Financial Inc. now owns 540,279 shares of the company’s stock worth $68,107,000 after buying an additional 365,910 shares during the last quarter. FDO Partners LLC purchased a new stake in Clorox during the first quarter worth $614,000. BlackRock Inc. increased its stake in Clorox by 11.7% in the first quarter. BlackRock Inc. now owns 642,068 shares of the company’s stock worth $80,940,000 after buying an additional 67,130 shares during the last quarter. Finally, BlackRock Group LTD increased its stake in Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock worth $200,775,000 after buying an additional 245,650 shares during the last quarter. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Clorox Co. (NYSE:CLX) traded down 1.82% on Tuesday, reaching $122.06. The company’s stock had a trading volume of 1,205,100 shares. Clorox Co. has a 52-week low of $117.52 and a 52-week high of $140.47. The stock has a market cap of $15.80 billion, a price-to-earnings ratio of 24.81 and a beta of 0.30. The firm’s 50-day moving average price is $127.67 and its 200-day moving average price is $130.07.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.28 by $0.02. The business earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The company’s revenue for the quarter was up 2.8% compared to the same quarter last year. During the same period in the prior year, the business posted $1.44 EPS. On average, equities analysts expect that Clorox Co. will post $5.49 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be paid a $0.80 dividend. This represents a $3.20 dividend on an annualized basis and a dividend yield of 2.62%. The ex-dividend date is Monday, October 24th. Clorox’s payout ratio is 64.91%.

CLX has been the subject of a number of recent research reports. Jefferies Group restated a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. B. Riley restated a “neutral” rating and set a $109.00 target price on shares of Clorox in a research report on Tuesday, August 9th. Atlantic Securities initiated coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 target price for the company. Deutsche Bank AG restated a “hold” rating and set a $134.00 target price (up previously from $130.00) on shares of Clorox in a research report on Sunday, July 24th. Finally, Zacks Investment Research downgraded Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday, July 5th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $128.90.

In other news, COO Nikolaos A. Vlahos sold 925 shares of the stock in a transaction on Wednesday, August 10th. The stock was sold at an average price of $133.07, for a total value of $123,089.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Laura Stein sold 38,882 shares of the stock in a transaction on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total value of $5,120,370.58. Following the completion of the transaction, the executive vice president now owns 48,501 shares of the company’s stock, valued at $6,387,096.69. The disclosure for this sale can be found here. 0.74% of the stock is owned by insiders.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Receive News & Stock Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related stocks with our FREE daily email newsletter.